Tredje AP-fonden’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Buy |
290,742
+4,078
| +1% | +$224K | 0.13% | 111 |
|
|
2025
Q1 | $20.3M | Buy |
286,664
+63,000
| +28% | +$4.45M | 0.19% | 105 |
|
|
2024
Q4 | $14.7M | Buy |
223,664
+194,334
| +663% | +$12.8M | 0.13% | 128 |
|
|
2024
Q3 | $2.06M | Hold |
29,330
| – | – | 0.02% | 362 |
|
|
2024
Q2 | $2.41M | Sell |
29,330
-463
| -2% | -$38.1K | 0.02% | 320 |
|
|
2024
Q1 | $2.6M | Hold |
29,793
| – | – | 0.03% | 320 |
|
|
2023
Q4 | $2.87M | Sell |
29,793
-1,185
| -4% | -$114K | 0.04% | 298 |
|
|
2023
Q3 | $2.74M | Sell |
30,978
-2,883
| -9% | -$255K | 0.04% | 293 |
|
|
2023
Q2 | $2.94M | Sell |
33,861
-5,547
| -14% | -$481K | 0.04% | 301 |
|
|
2023
Q1 | $3.83M | Buy |
39,408
+1,914
| +5% | +$186K | 0.06% | 233 |
|
|
2022
Q4 | $3.88M | Sell |
37,494
-239
| -0.6% | -$24.7K | 0.07% | 214 |
|
|
2022
Q3 | $3.2M | Buy |
+37,733
| New | +$3.2M | 0.07% | 221 |
|